Sign in
4

Changes in Ownership

LEXICON PHARMACEUTICALS, INC. Filed Acc 0001127602-24-004455

Options or other derivatives

  • Chief Executive Officer acquired 1,540,840 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

COATS LONNEL · Chief Executive Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2024-02-08 Grant or award : show line 1 in the form Restricted Stock Units +770,420 770,420 D
2024-02-08 Grant or award : show line 2 in the form Stock Option (Right to Buy) +770,420 770,420 D
Loading xslF345X05/form4.xml…